On this page
Neonatal diabetes (KCNJ11)
This form of diabetes is caused by genetic changes, most commonly in the KCNJ11 gene, affecting how the body controls blood sugar levels. It requires early diagnosis and careful management, typically involving medication rather than insulin injections, to prevent complications.
Available at Jeen Health
Clinical tests that include this
Overview
Neonatal diabetes, sometimes called permanent neonatal diabetes mellitus (PNDM) or transient neonatal diabetes mellitus (TNDM) depending on its duration, is a very rare form of diabetes that presents in infants younger than six months old [PMID:24072030]. Unlike type 1 or type 2 diabetes, which typically develop later in life, neonatal diabetes is caused by specific genetic changes that affect the pancreas's ability to produce or release insulin effectively. It is distinct from other forms of diabetes and requires a specific diagnostic approach and management strategy. The condition affects approximately 1 in 90,000 to 160,000 live births.
Symptoms & clinical features
The primary symptom of neonatal diabetes is high blood sugar, known as hyperglycaemia. Affected infants may also experience excessive thirst, frequent urination, and dehydration. Despite a good appetite, some babies might show poor weight gain or failure to thrive. Other symptoms can include lethargy and, in severe cases, diabetic ketoacidosis, which is a life-threatening complication where the body produces high levels of blood acids called ketones [PMID:23788169]. In some instances, infants with specific genetic causes of neonatal diabetes might also have developmental delays or neurological symptoms, although these are less common with KCNJ11-related disease.
Video: Genetics 101
Affected organs
The primary organ affected in neonatal diabetes is the pancreas, specifically the beta cells within the islets of Langerhans, which are responsible for producing insulin. Insulin is a hormone vital for regulating blood glucose levels. When beta cells do not function correctly, either by not producing enough insulin or by not releasing it properly, blood sugar levels rise. Over time, persistently high blood sugar can impact other body systems, including the kidneys, eyes, and nerves, similar to other forms of diabetes if not properly managed.
Risks & severity
The severity of neonatal diabetes can vary, even within the same genetic cause. Untreated, the condition can lead to severe health problems, including developmental issues and life-threatening complications like diabetic ketoacidosis. With early diagnosis and appropriate management, many individuals with KCNJ11-related neonatal diabetes can achieve good blood sugar control. The duration of the condition can also vary; some forms of neonatal diabetes are transient, meaning they resolve within the first year of life but may reappear later, while others are permanent [PMID:24072030]. Most KCNJ11-related cases are permanent.
Genetic causes
Neonatal diabetes can be caused by changes in several different genes, but one of the most common causes is a pathogenic variant in the KCNJ11 gene. This gene provides instructions for making a protein that is a crucial component of the ATP-sensitive potassium (KATP) channel. These channels are found on the surface of pancreatic beta cells and play a vital role in regulating insulin release. When blood sugar levels rise, these channels normally close, leading to insulin secretion [PMID:19478149]. Pathogenic variants in KCNJ11 can cause the KATP channel to remain open too frequently, which in turn prevents the beta cells from releasing enough insulin, leading to high blood sugar.
- KCNJ11 potassium inwardly rectifying channel subfamily J member 11
Inheritance pattern
Neonatal diabetes caused by pathogenic variants in KCNJ11 is typically inherited in an autosomal recessive pattern. This means that a child must inherit two copies of the altered gene - one from each parent - to develop the condition. If both parents are carriers of a single pathogenic KCNJ11 variant, they usually do not show symptoms themselves. However, for each child they have, there is a 25% chance the child will inherit two altered copies and develop the condition, a 50% chance the child will be a carrier like the parents, and a 25% chance the child will inherit two unaffected copies of the gene.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
Diagnosis & testing
Diagnosis of neonatal diabetes is usually suspected based on clinical signs of hyperglycaemia in an infant under six months old. Confirmation often involves genetic testing, which can identify pathogenic variants in genes like KCNJ11. Genetic testing for neonatal diabetes is typically performed via an NHS Genomic Medicine Service (GMS) approved laboratory, often following a referral from a paediatrician or endocrinologist. Relevant NHS R-codes for genetic testing for diabetes conditions, including neonatal diabetes, exist within the GMS. Genetic counselling is an integral part of this process, providing families with information about the condition, inheritance patterns, and the implications of genetic test results.
Management & lifestyle
Management of neonatal diabetes caused by KCNJ11 variants often differs significantly from other types of diabetes. A key treatment approach involves the use of sulfonylurea medications, such as glibenclamide, which can help close the KATP channels in the pancreatic beta cells, thereby stimulating insulin release [PMID:23788169]. Many infants can successfully transition from insulin injections to oral sulfonylureas. Management plans are individualised and involve close monitoring of blood sugar levels, dietary advice, and regular follow-up with a paediatric diabetes specialist team. The aim is to achieve optimal blood sugar control to promote healthy growth and development and prevent long-term complications.
UK care pathway
In the UK, individuals suspected of having neonatal diabetes would typically enter the NHS Genomic Medicine Service (GMS) pathway. Referral to clinical genetics or a paediatric endocrinology team is common for assessment and genetic testing, which is often facilitated by an NHS R-code for conditions like neonatal diabetes. Genetic counsellors play a crucial role in supporting families through the diagnostic process, explaining inheritance patterns and potential implications for family members.
Frequently asked questions
What is the difference between neonatal diabetes and type 1 diabetes?
Neonatal diabetes occurs in the first six months of life due to specific genetic changes affecting insulin production or release. Type 1 diabetes typically develops later in childhood or adulthood and is an autoimmune condition where the body's immune system mistakenly attacks insulin-producing cells.
Can neonatal diabetes be cured?
Neonatal diabetes caused by KCNJ11 variants is a lifelong condition, but it can often be effectively managed with medication, typically oral sulfonylureas. This treatment can help control blood sugar levels, but it does not 'cure' the underlying genetic cause.
How is neonatal diabetes treated in the UK?
In the UK, treatment often involves oral sulfonylurea medications, which help the pancreas release insulin. This can sometimes allow infants to stop insulin injections. Management is guided by a specialist paediatric diabetes team, including regular monitoring and dietary advice.
If my child has neonatal diabetes, what does this mean for future children?
If neonatal diabetes is caused by an autosomal recessive gene variant, like in KCNJ11, and both parents are carriers, there is a 25% chance for each future child to also have the condition. Genetic counselling can provide personalised risk assessments and options for family planning.
Are there other symptoms besides high blood sugar?
While high blood sugar is the main symptom, infants may also experience excessive thirst, frequent urination, dehydration, and poor weight gain despite a good appetite. In some very rare cases, with specific genetic causes, developmental delays might also be present, though this is less common with KCNJ11.